- Trials with a EudraCT protocol (1,586)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,586 result(s) found for: Disease management.
Displaying page 1 of 80.
EudraCT Number: 2006-001923-20 | Sponsor Protocol Number: PALIFERMIN EXPANDED ACCESS PROTOCO | Start Date*: 2006-04-27 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: Palifermin use in patients , out of clinical investigation, which are receiving chemioterapic therapy with staminal cells to reduce severuty and incidence of mucositis. | |||||||||||||
Medical condition: mucositis | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004749-14 | Sponsor Protocol Number: 07_DOG13_104 | Start Date*: 2009-02-12 | ||||||||||||||||
Sponsor Name:Christie Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: Assessing the Feasibility of a Single Blind Randomised Controlled Trial to Measure the Effectiveness of D-Alpha-Tocopherol in the Management of Oral Mucositis in Patients Undergoing Conditioning fo... | ||||||||||||||||||
Medical condition: This trial will assess the D-alpha-Tocopherol in the management of Oral Mucositis. Nutritional status will be assessed using the patient generated subjective oral assessment tool to monitor cancer... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-015659-26 | Sponsor Protocol Number: 2009-015659-26 | Start Date*: 2010-01-22 | |||||||||||||||||||||
Sponsor Name:Karolinska Institutet | |||||||||||||||||||||||
Full Title: Cortical and hormonal stress responses to pain management with morphine in standard clinical dosage | |||||||||||||||||||||||
Medical condition: Neonatal pain | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002595-13 | Sponsor Protocol Number: 18F-AV-45-A18 | Start Date*: 2013-03-01 | |||||||||||
Sponsor Name:AVID RADIOPHARMACEUTICALS, INC. | |||||||||||||
Full Title: A randomized, multicenter, multicountry study to evaluate the effectiveness of Florbetapir (18F) PET imaging in changing patient management and to evaluate the relationship between Florbetapir (1... | |||||||||||||
Medical condition: Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003442-33 | Sponsor Protocol Number: D8480C00038 | Start Date*: 2005-11-22 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Phase II, Randomised, Factorial, Double-blind Study to Investigate the Management of AZD2171-induced Hypertension and Efficacy of AZD2171 at Doses of 30 mg and 45 mg in Patients with Advanced Sol... | ||
Medical condition: Management of AZD2171-induced hypertension in patients with advanced solid tumours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011233-27 | Sponsor Protocol Number: 09/WNo02/7 | Start Date*: 2009-09-10 | |||||||||||
Sponsor Name:North Wales NHS Trust | |||||||||||||
Full Title: Comparison of efficacy of concentration with volume of local anaesthetics in femoral-sciatic blocks for total knee replacement | |||||||||||||
Medical condition: No medical condition or disease under investigation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018050-34 | Sponsor Protocol Number: V1.0,18.08.2009 | Start Date*: 2010-06-04 |
Sponsor Name:Medizinische Universität Wien,Univ.Klinik f.Anästhesie, Intensivmedizin und Schmerztherapie | ||
Full Title: Perioperative fluid management in patients receiving cadaveric renal transplants – Effects of normal saline versus balanced infusates on the incidence of electrolyte and acid-base disturbances | ||
Medical condition: patients receiving cadaveric renal transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002484-99 | Sponsor Protocol Number: 2006 | Start Date*: 2007-01-10 |
Sponsor Name:South Devon Health Care NHS Foundation Trust | ||
Full Title: The Use of Nebulised Magnesium Sulphate in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) | ||
Medical condition: We propose a study to examine whether adjuvant magnesium therapy administered via nebuliser is effective in the management of patients with acute exacerbations of COPD. The findings should help to ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000235-27 | Sponsor Protocol Number: S-20120216 | Start Date*: 2013-02-19 | |||||||||||
Sponsor Name:Odense universitets Hospital | |||||||||||||
Full Title: Interscalener blockade for surgery on the shoulder, a comparison of two dosing regimens: Fixed intermittent bolus with the possibility of PCA (Patient controlled administration) Vs. continuous infu... | |||||||||||||
Medical condition: Shoulder frcture Rotator cuff leasion Shoulder alluplastic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002226-22 | Sponsor Protocol Number: 2.0 | Start Date*: 2019-04-30 |
Sponsor Name:Medical University of Vienna | ||
Full Title: The Impact of Target Temperature Management on Drug Metabolism | ||
Medical condition: Patients after successful cardiopulmonary resuscitation who undergo target temperature management for 24h hours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004347-37 | Sponsor Protocol Number: VSV2016b | Start Date*: 2017-01-31 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Femoralblock in endovenous laser | ||
Medical condition: venous disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004854-19 | Sponsor Protocol Number: DSC/03/2357/06 | Start Date*: 2005-04-25 |
Sponsor Name:Italfarmaco S.p.A. | ||
Full Title: A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s ... | ||
Medical condition: Crohn's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005272-19 | Sponsor Protocol Number: 20190184 | Start Date*: 2023-01-08 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction | |||||||||||||
Medical condition: Dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002173-26 | Sponsor Protocol Number: VX21-CTX001-151 | Start Date*: 2021-10-05 | |||||||||||
Sponsor Name:VERTEX PHARMACEUTICALS INCORPORATED | |||||||||||||
Full Title: A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Severe Sickle Cell Disease | |||||||||||||
Medical condition: Severe Sickle Cell Disease (SCD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002080-27 | Sponsor Protocol Number: KPS 2008-01 | Start Date*: 2008-08-06 | ||||||||||||||||
Sponsor Name:Greater Glasgow Health Board/University of Glasgow | ||||||||||||||||||
Full Title: A randomised, double-blind controlled trial of ketamine versus placebo in conjunction with best pain management in neuropathic pain in cancer patients | ||||||||||||||||||
Medical condition: Patients who have neuropathic pain related to cancer and/or treatment for cancer (surgical, chemotherapy or radiotherapy) which has resulted in neuropathic pain. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-005712-40 | Sponsor Protocol Number: 1253/08 | Start Date*: 2008-09-19 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Evaluation of postoperative pain management with thoracic paravertebral block using levobupivacaine associated with sufentanil | |||||||||||||
Medical condition: postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002216-25 | Sponsor Protocol Number: PDT409 | Start Date*: 2006-06-26 |
Sponsor Name:Amersham Health, S.A. (filial de GE Healthcare Ltd) | ||
Full Title: Ensayo en fase 4 multicéntrico, aleatorizado, abierto y comparativo para evaluar las modificaciones en el manejo clínico después de una tomografía con DaTSCAN en sujetos con parkinsonismo clínicame... | ||
Medical condition: The subjects included in this trial will have clinically uncertain parkinsonism in a general neurologist setting. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) IT (Completed) DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-004939-39 | Sponsor Protocol Number: GS-EU-174-1403 | Start Date*: 2015-05-26 | |||||||||||
Sponsor Name:Gilead Sciences International Ltd. | |||||||||||||
Full Title: Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi... | |||||||||||||
Medical condition: Chronic Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Prematurely Ended) ES (Prematurely Ended) BG (Prematurely Ended) GR (Completed) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022114-12 | Sponsor Protocol Number: MW012 | Start Date*: 2010-12-20 |
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | ||
Full Title: Multizentrische prospektive randomisierte kontrollierte offene Phase IV Studie zur Evaluation von Synergien zwischen WS® 1070 und strukturiertem Stressmanagement bei Patienten mit nachlassender Lei... | ||
Medical condition: Asthenia and decreased concentration capacity as well as fatigue and feeling of weakness along with subjective stress | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016082-29 | Sponsor Protocol Number: era-gastro-pancreas-001 | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:Erasme hospital | |||||||||||||
Full Title: Role of Lanreotide in the Management of Paraduodenal Pancreatitis | |||||||||||||
Medical condition: Paraduodenal pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
